Posts Tagged ‘obesity treatment’

It is taking a long time for diet culture to fade into oblivion. But we are well down that road when celebrity culture meets obesity science in a new book by Oprah Winfrey and Ania Jastreboff. It’s remarkable, really, that we have come to a time when one of the most iconic persons in the […]

“People who come off slimming jabs regain weight four times faster than dieters.” The year is young, but already we have this contender for the dumbest headline of the year about obesity. It is helpful only as a reminder of how pervasive the implicit bias about obesity and its treatment is. Slimming Jabs? The headline […]

Unless you’ve been living under a rock this January, you have probably noticed that this is no longer diet season. U.S. News seems to have abandoned their longstanding annual ranking of “Best Diets,” perhaps because no one is paying attention in this age of drugs related to Ozempic. Now, more people are dealing with excess […]

While all eyes in obesity focused on the launch of a daily oral tablet for ongoing treatment, Arrowhead Pharmaceuticals brought us a little surprise yesterday. They presented early data from phase one studies of two gene silencing therapies for obesity. Though these data are quite preliminary, they offer a signal of great promise for a […]

A big change is afoot and the hype is cranking up. With the launch of Wegovy tablets by Novo Nordisk yesterday, we are seeing some very big expectations expressed for a new era in obesity care. The stock market has boosted the value of Novo stock by 15 percent since FDA approved these tablets. Yesterday […]

Yet another careful study of shifts in spending on food and restaurant purchases tells us that yes indeed, GLP-1s will likely reshape markets for food. Food systems already feel it and are beginning to adapt. But truthfully, this is probably just a faint, flickering indication of what’s to come. A Careful Analysis of Food Purchasing […]

On this Christmas Day, we have a simple wish. It is the wish that equitable access to obesity care, free from stigma and blame, should be available to all. Right now, that is clearly not true. And there’s a lot to suggest that the trends are headed in precisely the wrong direction. Skimming the Cream […]

It is no secret that alcohol use disorder is a risk after metabolic and bariatric surgery. The risk rises as time passes after surgery, with one study finding three percent of patients followed for a median of six years having one alcohol use disorder diagnosis in their medical records. Another study found that three years […]

We strongly suspect that advanced oral obesity medicines may be a defining milestone for 2026. This is because they have the potential to fill an important gap in obesity therapy – the unmet need for therapies that people can persistently take to maintain control of this chronic disease. Late yesterday, FDA granted approval for the […]

News from Lilly about orforglipron this week points to what might be the next big development for GLP-1 medicines. The company announced topline results for a weight maintenance study of orforglipron and this first glimpse has us thinking that maintain might be the magic word in obesity care next year. The topline come from the […]